Frontiers in Pharmacology | Respiratory Pharmacology

Editorial

Published on 14 Jan 2025

Editorial: Methods in respiratory pharmacology 2023

in Respiratory Pharmacology

Nadia Milad
Giulio Cabrini
Maria Cordina

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527053

503 views

Original Research

Published on 13 Jan 2025

CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway

in Respiratory Pharmacology

Hao Qu
Yan Fang
Feng Zhang
Wenwen Liu
Shengkai Xia
Wenzhe Duan
Kun Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502165

1,026 views

Editorial

Published on 13 Jan 2025

Editorial: Model organisms in respiratory pharmacology 2023

in Respiratory Pharmacology

Alexandra McCarron
Ranu Surolia
Livia Ruffini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1540222

606 views
1 citation

Original Research

Published on 09 Jan 2025

High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

in Respiratory Pharmacology

Zhishen Ruan
Chunbin Wang
Shasha Yuan
Yiling Fan
Bo Xu
Xiaodong Cong
Dan Li
Qing Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1460407

1,758 views

Original Research

Published on 08 Jan 2025

Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway

in Respiratory Pharmacology

Gang Liu
Bin-Bin Dong
Zi-Heng Ding
Chao Lan
Chang-Ju Zhu
Qi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469783

742 views

Original Research

Published on 07 Jan 2025

Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin

in Respiratory Pharmacology

Liliane Patrícia Gonçalves Tenório
Felipe Henrique da Cunha Xavier
Mônica Silveira Wagner
Kayo Moreira Bagri
Erick Gabriel Alves Ferreira
Romulo Galvani
Claudia Mermelstein
Adriana Cesar Bonomo
Wilson Savino
Emiliano Barreto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504556

820 views

Review

Published on 03 Jan 2025

Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease

in Respiratory Pharmacology

Mengjiao Xu
Peng Feng
Jun Yan
Lei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474310

1,459 views
1 citation

Original Research

Published on 03 Jan 2025

A novel non-invasive murine model for rapidly testing drug activity via inhalation administration against Mycobacterium tuberculosis

in Respiratory Pharmacology

Xirong Tian
Yamin Gao
Chunyu Li
Wanli Ma
Jingran Zhang
Yanan Ju
Jie Ding
Sanshan Zeng
H. M. Adnan Hameed
Htin Lin Aung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400436

1,003 views

Original Research

Published on 03 Jan 2025

α-Bisabolol alleviates diesel exhaust particle-induced lung injury and mitochondrial dysfunction by regulating inflammatory, oxidative stress, and apoptotic biomarkers through the c-Jun N-terminal kinase signaling pathway

in Respiratory Pharmacology

Sumaya Beegam
Nur Elena Zaaba
Ozaz Elzaki
Abderrahim Nemmar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485101

690 views
1 citation

Original Research

Published on 17 Dec 2024

Mitigating inflammation and fibrosis: the therapeutic potential of quercetin liposomes in COPD

in Respiratory Pharmacology

Changfeng Yin
Yushan Tian
An Yan
Hongjuan Wang
Fengjun Lu
Xianmei Li
Xiao Li
Shulei Han
Ruijuan Miao
Huan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503283

1,061 views

Case Report

Published on 22 Nov 2024

Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review

in Respiratory Pharmacology

Ioannis S. Pateras
Konstantinos Kostopanagiotou
Menelaos G. Samaras
Anna Koumarianou
Mina Koutrouli
Nikolaos Korodimos
Katerina Kampoli
Vasiliki Apollonatou
Effrosyni Manali
Stylianos Loukides

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1482154

879 views

Review

Published on 13 Nov 2024

Pyroptosis in asthma: inflammatory phenotypes, immune and non-immune cells, and novel treatment approaches

in Respiratory Pharmacology

Yuqiu Hao
Wenrui Wang
Lin Zhang
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1452845

1,343 views

Review

Published on 08 Nov 2024

Bacteria and fungi of the lung: allies or enemies?

in Respiratory Pharmacology

Enrico Garaci
Marilena Pariano
Emilia Nunzi
Claudio Costantini
Marina Maria Bellet
Cinzia Antognelli
Matteo Antonio Russo
Luigina Romani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497173

1,016 views

Case Report

Published on 07 Nov 2024

Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review

in Respiratory Pharmacology

Ya Liu
Ying Huang
Xiang Liu
Danxia Wang
Yixiang Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420046

1,280 views
2 citations

Original Research

Published on 28 Oct 2024

Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses

in Respiratory Pharmacology

Yi Luan
Desheng Xian
Changwen Zhao
Xin Qing
Hanlin He
Kaixuan Zheng
Wenjun Song
Taijiao Jiang
Wenjian Wang
Chaohui Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441233

2,069 views

Correction

Published on 25 Oct 2024

Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

in Respiratory Pharmacology

Cataldo Martucci
Andrew Dennis Allen
Nadia Moretto
Valentina Bagnacani
Alessandro Fioni
Riccardo Patacchini
Maurizio Civelli
Gino Villetti
Fabrizio Facchinetti

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497520

405 views